{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:57:23Z","timestamp":1773320243197,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005656","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":40,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005656.pub2","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T01:11:33Z","timestamp":1202260293000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Intravitreal steroids for macular edema in diabetes"],"prefix":"10.1002","author":[{"given":"Donald A","family":"Grover","sequence":"first","affiliation":[{"name":"Strong Memorial Hospital; Department of Ophthalmology; Box 659 601 Elmwood Avenue Rochester NY USA 14642"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjing","family":"Li","sequence":"additional","affiliation":[{"name":"Cochrane Eyes and Vision Group US Project; Johns Hopkins Bloomberg School of Public Health 615 North Wolfe Street. E6006 Baltimore USA MD 21205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin CW","family":"Chong","sequence":"additional","affiliation":[{"name":"Save Sight Institute; Department of Ophthalmology and Eye Health; Sydney Hospital & Sydney Eye Hospital 8 Macquarie Street Sydney GPO BOX 4337 Australia NSW 2001"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD005656.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1600-0420.2006.00700.x","article-title":"Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial","volume":"84","author":"Audren","year":"2006","journal-title":"Acta ophthalmologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD005656.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD005656.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajo.2005.05.021","article-title":"Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema","volume":"140","author":"Avitabile","year":"2005","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD005656.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2006.22.200","article-title":"Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study","volume":"22","author":"Jonas","year":"2006","journal-title":"Journal of Ocular Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0005|cit5","unstructured":"Kuppermann BD Blumenkranz MS Haller JA Williams GA Posurdex Study Group An Intravitreous Dexamethasone Bioerodible Drug Delivery System for the Treatment of Persistent Diabetic Macular Edema Association for Research in Vision and Ophthalmology Annual Meeting 2003"},{"issue":"3","key":"10.1002\/14651858.CD005656.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archopht.125.3.309","article-title":"Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema","volume":"125","author":"Kuppermann","year":"2007","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0007|cit7","unstructured":"Nancy Groves Reviewed by Pearson P A Steroids implant reduces retinal thickness, improves vision Ophthalmology Times 24 6"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0008|cit8","unstructured":"Pearson PA Baker CW Eliott D Ip MS Morese LS Callanan DG Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: 2 Year Results Association for Research in Vision and Ophthalmology Annual Meeting 2004"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0009|cit9","unstructured":"Pearson PA Baker CW Eliott D Ip MS Morese LS Callanan DG Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema American Academy of Ophthalmology Annual Meeting 2002"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0010|cit10","unstructured":"Pearson PA Eliott D Baker CW Ip MS Morese LS Callanan DG Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema Association for Research in Vision and Ophthalmology Annual Meeting 2003"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0011|cit11","unstructured":"Nancy Groves Reviewed by Pearson P A Patients with DME have response to fluocinolone acetonide intravitreal implant in study outcomes Ophthalmology Times 38"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0012|cit12","unstructured":"Pearson PA Bevy B Fluconolone Acetonide Implant Study Group Fluocinolone Acetonide Intravitreal Implant to Treat Diabetic Macular Edema: 2-year Results of a Multi-Center Clinical Trial Association for Research in Vision and Ophthalmology Annual Meeting 2005"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0013|cit13","unstructured":"Pearson PA Levy B Comstock T Fluocinolone Acetonide Implant Study Group Fluocinolone Acetonide Intravitreal Implant to Treat Diabetic Macular Edema: 3-Year Results of a Multi-Center Clinical Trial Association for Research in Vision and Ophthalmology Annual Meeting 2006"},{"issue":"9","key":"10.1002\/14651858.CD005656.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal Triamcinolone for Refractory Diabetic Macular Edema Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial","volume":"113","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD005656.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0016|cit16","unstructured":"Bandello F Polito A Dimastrogiovanni A Palsslos I Intravitreal triamcinolone associated with grid laser photocoagulation for diffuse diabetic macular edema Macular Society Annual Meeting 2004"},{"issue":"10","key":"10.1002\/14651858.CD005656.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1167\/iovs.05-0297","article-title":"Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical tiral","volume":"46","author":"Bonini-Filho","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1002\/14651858.CD005656.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ophtha.2005.03.023","article-title":"Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema","volume":"112","author":"Cardillo","year":"2005","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD005656.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000088385","article-title":"Intravitreal cortisone injection for refractory diffuse diabetic macular edema","volume":"219","author":"Er","year":"2005","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD005656.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajo.2004.07.007","article-title":"Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide","volume":"138","author":"Jonas","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD005656.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bjo.2004.062596","article-title":"Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema","volume":"89","author":"Spandau","year":"2005","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD005656.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/1080768041725308","article-title":"A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema","volume":"20","author":"Verma","year":"2004","journal-title":"Journal of Ocular Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0023|cit23","unstructured":"A randomized trial comparing intravitreal triamcinolone acetonide and laser photocoagulation for DME. Ongoing study June 2004"},{"issue":"4","key":"10.1002\/14651858.CD005656.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1056-8727(03)00038-2","article-title":"Risk factors for diffuse and focal macular edema","volume":"18","author":"Aroca","year":"2004","journal-title":"Journal of Diabetes Complications"},{"issue":"43","key":"10.1002\/14651858.CD005656.pub2-BIB0025|cit25","first-page":"937","article-title":"Blindness caused by diabetes: Massachusetts, 1987-1994","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1002\/14651858.CD005656.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.icu.0000120711.35941.76","article-title":"Corticosteroids in posterior segment disease: an update on new delivery systems and new indications","volume":"15","author":"Ciulla","year":"2004","journal-title":"Current Opinions in Ophthalmology"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/112067219800800301","article-title":"Diabetic macular edema","volume":"8","author":"Cunha-Vaz","year":"1998","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial (DCCT) Research Group","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0029|cit29","unstructured":"Deeks JJ Higgins JPT Altman DG Analysing and presenting data. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 8 In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0161-6420(78)35693-1","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy: the second report of DRS findings","volume":"85","author":"Diabetic Retinopathy Study Research Group","year":"1978","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD005656.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1","volume":"103","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1985","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD005656.pub2-BIB0032|cit32","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0033|cit33","unstructured":"Higgins JPT Green S Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6 In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd"},{"key":"10.1002\/14651858.CD005656.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse DME","volume":"121","author":"Jonas","year":"2003","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD005656.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.eye.6701512","article-title":"Intravitreal triamcinolone as a primary therapy in diabetic macular oedema","volume":"19","author":"Karacorlu","year":"2005","journal-title":"Eye"},{"issue":"12","key":"10.1002\/14651858.CD005656.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0161-6420(84)34102-1","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema","volume":"91","author":"Klein","year":"1984","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD005656.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD005656.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(04)00109-2","article-title":"Macular edema","volume":"49","author":"Tranos","year":"2004","journal-title":"Survey of Ophthalmology"},{"issue":"1998","key":"10.1002\/14651858.CD005656.pub2-BIB0039|cit39","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UKPDS Group","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD005656.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.eye.6701476","article-title":"Epidemiology of diabetic retinopathy and macular oedema: a systematic review","volume":"18","author":"Williams","year":"2004","journal-title":"Eye"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005656.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005656.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:52:38Z","timestamp":1628545958000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005656.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005656.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005656.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}